Middle transcription of bacteriophage Mu requires Escherichia coli RNA polymerase holoenzyme and a Mu-encoded protein, Mor. Consistent with these requirements, the middle promoter, P m , has a recognizable -10 region but lacks a -35 region. Mutagenesis of this promoter (from -70 to +10) was performed using mutagenic oligonucleotide-directed PCR. The resulting fragments were cloned into a promoter-lacZ fusion vector and analyzed for promoter activity by assaying β-galactosidase production. Single point mutations with a Down phenotype were clustered in three regions: the -10 region, the Mor footprint region and the spacer between them. Gel retardation experiments with purified Mor protein and promoter mutants demonstrated that sequences important for Mor binding are located within the Mor footprint region and lead us to propose the existence of a dyad symmetry element involved in Mor binding. In agreement with this prediction, glutaraldehyde crosslinking of Mor in solution generated a species with the size of a dimer. These experiments also identified an unusual group of mutations located in the spacer region adjacent to the Mor footprint. These mutations alter promoter activity without affecting Mor binding. A circular permutation assay revealed that Mor does not introduce a significant bend upon binding to its target sequence.
INTRODUCTION
Bacteriophage Mu is a temperate bacteriophage of Escherichia coli K-12 and several other enteric bacteria (1) . During lytic development Mu utilizes host RNA polymerase (2) to transcribe three sets of genes: early, middle and late. Expression of the early operon from P e is independent of de novo protein synthesis and phage replication and is stimulated by E.coli integration host factor (IHF) (3) . Middle operon transcription initiating at P m requires phage replication and the early gene product Mor (4) (5) (6) and results in expression of C, the activator of late transcription (7) (8) (9) . The middle promoter, P m , possesses characteristic features of a promoter under positive control (10) : it has a recognizable -10 hexamer but lacks similarity to the canonical -35 region.
Previous deletion and footprinting analyses demonstrated that sequences upstream of -62 and downstream of +10 are dispensable for promoter activity and that Mor protects P m sequences from -56 to -33 against cleavage by DNase I (11) .
Mor is a small protein of 129 amino acid residues (14.7 kDa) (6) with an acidic N-terminal region reminiscent of eukaryotic transcriptional activators (12) and a basic C-terminal region with some characteristics of the helix-turn-helix DNA binding motif (13) . Transcription from P m is activated by Mor and is carried out by E.coli RNA polymerase holoenzyme both in vivo and in vitro (6, 14) . The mechanism by which this activation occurs remains unknown. It might, for example, involve protein-protein interactions between Mor and RNA polymerase, conformational changes in the promoter DNA or a combination of both.
The goal of this study was to identify the sequence and structural features of the middle promoter which are involved in Mor-dependent activation.
MATERIALS AND METHODS

Media, chemicals and enzymes
Minimal medium with casamino acids (M9CA) was used in β-galactosidase assays (15) and during protein overexpression, LB (4) was used for other cell growth purposes. MacConkey lactose plates contained 50 g/l MacConkey agar (Difco). Ampicillin (Ap) (US Biochemical Corp.) and chloramphenicol (Cm) (Sigma) were used as necessary at 50 and 25 µg/ml respectively, unless indicated otherwise. Isopropyl-β-D-thiogalactopyranoside (IPTG) and o-nitrophenyl-β-galactopyranoside (ONPG) were from American Bioorganics. Radiolabeled compounds were from New England Nuclear Research Corp. Acrylamide, bisacrylamide, TEMED, Bradford reagent and heparin-agarose were from BioRad; protein molecular mass markers were from BioRad or Gibco BRL; ammonium persulfate, polyethyleneimine (PEI), phenylmethylsulfonyl fluoride (PMSF) and NP-40 were from Sigma Chemical Co. Glutaraldehyde was purchased from Fluka BioChemika. SeaKem ME and NuSieve GTG-agarose were from FMC Bioproducts. T4 polynucleotide kinase (PNK) was purchased from Promega Corporation. Shrimp alkaline phosphatase (SAP), dNTPs, Sequenase 2.0 and labeling and termination mixes were from US Biochemical Corp. EcoRI, BamHI, Taq polymerase and T4 DNA ligase were * To whom correspondence should be addressed from Boehringer Mannheim. All other restriction enzymes were from New England BioLabs.
Bacterial strains and strain construction
Strain MH10713, a derivative of strain BL21 (E.coli B, ompT, r b -, m b -, λDE3, pLysS) (16) containing expression plasmid pKM90 (14) , was used for protein production. All other strains were E.coli K-12. Strain JM109 (mcrA ∆pro-lac thi gyrA96 endA1 hsdR17 relA1 supE44 recA/ F′ traD36 lacI Q lacZ∆M15 proAB + ; 17) was used as the host for all plasmid constructs. The test strain for phenotypic assays of P m mutants, MH13312 (mcrA ∆pro-lac thi gyrA96 endA1 hsdR17 relA1 supE44 recA/ F′ lacI Q1 ∆lacZY pro + ) was constructed by introducing an F′ element-containing lacI Q1 and a lacZY deletion into a JM109 derivative spontaneously cured of its F′ element (MH13265). F′ pro + lacI Q1 ∆lacZY was constructed as follows. The F′ pro + lac + lacI Q1 plasmid from MH12668 (gal lac rpsL recA/F′ pro + lac + lacI Q1 , a Lac + revertant of MH7295; 7) was mated into MH595 (∆pro-lac trp rpsL Spc R , a Spc R derivative of strain 40; 18) and the resulting strain was transformed with pIA11 to allow transfer of ∆lacZY from pIA11 to the F′ element. Lac -Pro + homogenotes were isolated on MacConkey lactose plates and the F′ element was mated into MH13265. The resulting strain, MH13312, was used as the host strain for analysis of promoter mutants in plate and liquid assays. This strain combines the high transformation efficiency of JM109 (10 8 /µg pBR322) with low uninduced levels of β-galactosidase in P m -lacZ fusions due to the tight repression of P lacUV5 , which drives Mor production from the activator plasmid pKM78. Strain MH13335 was made by transformation of pKM78 into MH13312.
Plasmids and plasmid construction
Plasmid pKM54, containing Mu DNA from nucleotide (nt) 6831 to 10737 (6) was used as a template for PCR amplifications. pKM78 (6) was used to provide activator protein in trans from a P lacUV5 promoter. pKM90 (14) , containing mor cloned into the pT7-7 vector, was used for Mor production and purification. Plasmid pIA11 is a derivative of pLC1 (19) with a HpaI-SnaBI deletion removing most of the lacZ and lacY genes. Plasmid pIA12 is a derivative of pLC1 made by insertion of a 20 bp HindIII linker into the EcoRI site, destroying the upstream and retaining the downstream EcoRI site. All promoter fragments were cloned between EcoRI and BamHI sites of this vector. Plasmid pIA14 contains P m sequences from -62 to +10 cloned into pIA12. pIA40 was constructed by cloning a PCR product containing P m (-61 to +10) into the XbaI site of pBend2 (20) . Standard cloning methods were used (21) and competent cells were prepared by the CaCl 2 method (22) .
Oligonucleotide synthesis
Oligonucleotides were synthesized on an Applied Biosystems DNA synthesizer (Model 380B) using the phosphite triester method (23) . For mutagenic oligonucleotide-directed PCR (Mod-PCR) mutagenesis degeneracy was introduced into the targeted region of the oligonucleotide under conditions designed to result in a misincorporation rate of 0.25/nt (24) . For site-specific mutagenesis an equimolar mixture of nucleotides was delivered at the desired position. EcoRI and BamHI (for P m mutagenesis) or XbaI restriction sites (for pIA40 construction) were added at the 5′-ends of primers and were preceded by 3 nt for efficient digestion. Oligonucleotides were purified by ether extraction and ethanol precipitation (25) prior to use. Sequencing primers IRI21 and IRI22 contain vector sequences complementary to opposite strands of pIA12. Nucleotide sequences will be provided upon request.
PCR amplification and cloning of PCR products
PCR amplifications were carried out as recommended by Boehringer Mannheim in 100 µl reactions using 1 ng pKM54 DNA as template in a PTC-100 thermal cycler (MJ Research, Inc.) for 30 cycles (1 min at 94_C, 1 min at 50_C, 1 min at 72_C), followed by 7 min at 72_C. PCR products were extracted with phenol/chloroform, ethanol precipitated, resuspended in water and cut with EcoRI and BamHI. Products were separated in 4% (3:1 NuSieve GTG:SeaKem ME) gels in TBE (21), electroeluted onto DE81 paper (Whatman), ethanol precipitated, resuspended in water, ligated to pIA12 previously digested with EcoRI and BamHI and transformed into MH13335.
Sequence analysis
Plasmid templates for sequencing were isolated using a QIAprep spin purification kit (Qiagen), denatured in 0.2 M NaOH for 10 min at 65_C, neutralized, ethanol precipitated and sequenced using standard US Biochemicals protocols. Reactions were run on 6% sequencing gels, which were fixed, dried and exposed to X-OMAT AR film (Kodak) to visualize the sequence.
Protein purification
Plasmid pKM90 containing mor under the control of the T7 gene 10 promoter was transformed into MH10713, containing T7 RNA polymerase under P lacUV5 control. A fresh transformant was grown overnight in LB supplemented with 100 µg/ml Ap and 25 µg/ml Cm, inoculated into 1 l M9CA containing the same antibiotics and grown at 37_C to an A 600 of 0.6. After addition of IPTG to 0.5 mM cells were grown for 1 h at 37_C, pelleted by centrifugation for 10 min at 10 000 g, washed with 1× M9 and pelleted again. Pellets were frozen in a dry ice/ethanol bath and stored at -80_C overnight. Cells were thawed at room temperature for 15 min, resuspended in 15 ml buffer A (20 mM Tris-HCl, pH 7.9, 0.5 mM EDTA, 0.5 mM DTT, 0.4 mM PMSF, 5% glycerol) with 50 mM NaCl. The suspension was sonicated on ice and NP-40 was added to 0.1%. Following 15 min incubation on ice cell debris was removed by centrifugation at 20 000 g for 10 min (with very little loss of Mor). The resulting supernatant is called crude extract. PEI was added to the supernatant to 0.2%. After 30 min incubation on ice the precipitate was collected by centrifugation at 20 000 g for 10 min, washed in buffer A with 150 mM NaCl for 30 min on ice and collected by centrifugation again. Mor was eluted with buffer A containing 650 mM NaCl during a 30 min incubation on ice. Insoluble material was removed by centrifugation at 20 000 g for 10 min and the supernatant (PEI eluate) was subjected to (NH 4 ) 2 SO 4 precipitation at 23% (w/v). Precipitated proteins were pelleted at 20 000 g for 30 min, dissolved in 5 ml buffer B (50 mM Tris-HCl, pH 8.5, 0.5 mM EDTA, 0.5 mM DTT, 0.4 mM PMSF, 5% glycerol, 50 mM NaCl) and this ammonium sulfate precipitate was loaded onto a heparin-agarose column equilibrated with buffer B. The column was washed with buffer B (5 vol.) and proteins were eluted with a 50-500 mM NaCl gradient in buffer B; Mor eluted at 400 mM NaCl. Fractions containing Mor were dialyzed overnight against buffer A with 10% glycerol and aliquots frozen in a dry ice/ethanol bath and stored at -20_C. Protein concentration was determined using a Bradford assay (26) . Mor protein was 99% pure (as judged from an overloaded SDS gel); recovery was 20%.
RESULTS
Mutagenesis of the middle promoter
To determine the involvement of individual base pairs in activation of the middle promoter we mutagenized P m using a combination of mutagenic oligonucleotide-directed PCR (Mod-PCR; 24) and site-directed mutagenesis. We divided the promoter into nine regions of 6-12 bp ( Fig. 1 ) and performed mutagenesis of each region separately using degenerate oligonucleotide primers synthesized under conditions predicted to result in a misincorporation rate of 0.25/targeted base. The mutagenized fragments were cloned into the promoterless lacZ fusion vector pIA12 and transformed into a Lacstrain containing the activator plasmid pKM78 with mor under P lacUV5 control (Fig. 2) . The transformants were assayed for middle promoter activity by their color development on MacConkey lactose plates containing varying amounts of IPTG and were scored as Up, Down or Wild-type relative to the unmutagenized promoter construct. Phenotypic properties of the mutant populations are presented in Table 1 .
Mutagenesis of region I (-70 to -62) was performed first, resulting in a population with 4% Down mutants and 96% phenotypically Wild-type clones. DNA sequence analysis revealed that clones with Wild-type phenotype contained an average of 2.6 mutations in region I; the rare Down mutants contained mutations in both region I and other regions later shown to be required for promoter activity. The lack of deviation from Wild-type phenotype produced by mutations in region I and the finding by deletion analysis of P m (11) Figure 2 . Middle promoter in vivo assay system. Promoter fragments cloned between the EcoRI and BamHI sites in pIA12 are assayed for β-galactosidase expression following induction of Mor by IPTG induction of P lacUV5 on pKM78.
that sequences upstream of -62 and downstream of +10 are dispensable for Mor-dependent transcriptional activation prompted us to omit region I from the promoter used for further analysis. The remaining Mod-PCR analysis was carried out using a 'minimal P m promoter' containing sequences from -61 to +10 (regions II-VIII). Phenotypic properties of the resulting mutant populations (Table 1) allowed us to assign the promoter regions to two groups: 'important' regions, which are characterized by a large proportion of Down mutants, and 'unimportant' regions, with only a few Down mutants.
Regions III, IV and VI were considered 'important', since they contained 56, 44 and 59% Down mutants respectively (Table 1) . These regions overlap the Mor DNase I footprint and the -10 hexamer and therefore include sequences expected to be involved in binding of Mor and RNA polymerase. Consequently, we sequenced a large number of clones with both Wild-type and Down phenotypes from these regions. For 'unimportant' regions I, II, Va, Vb, VII and VIII, containing predominantly mutations conferring a Wild-type phenotype, all mutants with aberrant phenotypes and a number of phenotypically Wild-type clones were sequenced to verify the presence of substitutions and to identify any additional critical positions. Sequence analysis of region II (with only 7% Down mutants) revealed one additional important base pair; all Down mutants contained substitutions at position -51, indicating its importance, whereas positions -52 to -61 appeared dispensable for promoter activity. The distribution of promoter phenotypes within each mutagenized population was determined with a MacConkey lactose indicator plate assay. Single colonies were picked from transformation plates (LB with Ap and Cm) and patched onto MacConkey lactose plates containing antibiotics and increasing concentrations of IPTG (0, 10 -3 , 10 -2 , 10 -1 and 1 mM IPTG). Patch color was scored relative to control strains with pIA14 (Wild-type P m ) after overnight incubation at 32_C. Colonies induced at 10 -1 mM IPTG (as pIA14) were scored wild-type; those induced at 1 mM IPTG or not induced were called Down; mutants that turned red at 10 -2 mM IPTG were scored as Up. Region V was split into two halves (Va and Vb) after the first round of Mod-PCR because almost no single point mutations were recovered. The average frequency of base pair changes was calculated to reflect that of randomly sampled mutants based on the indicated number of sequenced clones. Promoter activity of mutants with single point mutations, deletions and insertions as determined by β-galactosidase assay. Strains were grown overnight in LB broth (with Ap + Cm), inoculated 1:100 into 2 ml M9CA (Ap + Cm) and grown to A 600 0.3-0.5 at 37_C. Mor production was induced by addition of IPTG to 2 mM and growth at 37_C for 1 h. Uninduced controls were assayed in parallel for each sample. Assays were as described (15) The misincorporation rate used was based on previous observations indicating a bias against the recovery of mutants from primers containing multiple mutations (19, 24) , however, in this study the distribution of mutations corresponded well with that predicted to be present in the oligonucleotide population based on the chosen misincorporation rate (the current experiments utilized an old DNA synthesizer and a different type of thermal cycler, both of which may have affected the mutation frequency observed). As a consequence of the higher than expected mutation frequency, many mutants contained multiple changes, making interpretation difficult. To recover mutants with single mutations in potentially important positions we carried out additional site-directed mutagenesis at several positions, targeting one base pair at a time. We also used site-directed mutagenesis to introduce spacing mutations, including 1 bp deletions within the T 7 tract and at -18, as well as 1 and 2 bp insertions between -17 and -18, positions chosen based on their lack of Down mutations.
A more quantitative analysis of promoter activity of mutant clones with single base pair changes, insertions and deletions was performed using a liquid β-galactosidase assay at least twice for each mutant in parallel with wild-type clones (Fig. 3) . Mutants with promoter activity in the range 50-150% of wild-type were arbitrarily grouped with wild-type; mutants with activities below or above this range were called Down or Up respectively. Base substitutions resulting in Down (3-50% of wild-type) or non-inducible (<3% of wild-type) promoter phenotypes are located in three regions. Mutations in the region from -13 to -8 reduce the match to the consensus -10 element (27) Up promoter mutations were recovered at positions -57, -31, +1, +8, +9 and +10. The base change at -57 increases the AT content of this region and could therefore increase binding of the α subunit of RNA polymerase (28) or alter the DNA flexibility or conformation (29) . Mutations at positions +1 to +10 might affect open complex formation, promoter clearance or messenger RNA stability (30) . The possible role of mutations at position -31 will be discussed later. 
Purification of Mor
To obtain purified Mor protein for gel shift analysis of the promoter mutants we expressed Mor from the pKM90 (14) plasmid containing mor cloned downstream of a strong T7 late promoter and ribosomal binding site in a strain carrying T7 RNA polymerase under the control of P lacUV5 . After induction Mor constituted ∼10% of the total cellular protein in the crude extract. Mor protein was purified using a combination of PEI precipitation, (NH 4 ) 2 SO 4 precipitation and heparin-agarose column chromatography ( Fig. 4 and Table 2 ). The final preparation of Mor protein was nearly homogenous (99% pure as determined by SDS-PAGE; Fig. 4 ) and was obtained with a recovery of ∼20% (Table 2 ).
Gel mobility shift assay
A gel mobility shift assay, which allows detection of proteinnucleic acid complexes by their altered electrophoretic mobility (31) , was developed for analysis of the interaction of purified Mor protein with wild-type and mutant promoter fragments. The apparent equilibrium constant K dapp of Mor (as a dimer and corrected for the fraction of active protein; see below) and P m at pH 7.9 and 25_C was estimated as 3.4 × 10 -9 M in the gel mobility shift assay (31) (data not shown) and as 2 × 10 -9 M in a filter binding assay (32) (data not shown); Mor was 23% active with respect to DNA binding as determined by the filter binding assay (data not shown). Gel mobility shift assay was then used to estimate relative binding affinities of Mor for 41 mutant promoter fragments. Purified Mor protein was used at 10, 100 and 1000 ng in 20 µl reactions (corresponding to 4, 40 and 400 nM active Mor dimer). Approximately 50% of a wild-type promoter fragment was shifted with only 10 ng protein, whereas the negative control fragment with unrelated sequence required 1000 ng to shift at all and even then gave only slight retardation, rather than a specific shifted complex. Some mutants gave gel shift patterns similar to that of the wild-type; others showed altered gel shift behavior. Typical results are presented in Figure 5A . Mutants such as -51T had lowered binding affinities for Mor as reflected by the need for 100 ng Mor to produce a detectable shift. Mutants like -36G had no detectable specific binding, behaving similarly to the negative control probe. Mutants -44T and -44A appeared to form unstable complexes, since the disappearance of the free probe was not accompanied by appearance of a specific shifted Mor-DNA complex.
A summary of the gel retardation results for all 41 mutants is shown in Figure 5B . Mutants with mutations outside the Mor footprint region from -56 to -33 exhibited wild-type binding regardless of their promoter activity in vivo (ranging from 0 to 209% of wild-type). Mutations under the Mor footprint could be divided into three major groups. Members of the first group were severely defective in binding, members of the second group had wild-type binding affinity and members of the third group had intermediate binding affinity. For mutations under the Mor footprint there was relatively good correlation between in vivo promoter activity of the mutants and their apparent ability to bind Mor; mutants -44A and T were exceptions in that they formed unstable complexes in the gel shift assay, but exhibited wild-type β-galactosidase levels in vivo.
Mutations with a significant effect on Mor binding were located internal to the Mor footprint in positions -51 to -36. Examination of this region revealed an imperfect 5 bp dyad symmetry element with a 6 bp spacer (shown in Fig. 5B ).
Mor crosslinking
Since many DNA binding proteins bind as dimers (33) to target sites containing dyad symmetry, we asked whether Mor could form dimers by treating Mor in solution at low concentration with the crosslinking agent glutaraldehyde (34) and examining the products on a denaturing SDS-polyacrylamide gel (Fig. 6) . With increasing length of glutaraldehyde treatment the amount of monomer diminished and a band corresponding to the predicted size for a dimer appeared. No bands corresponding to multimers were observed. Heat denatured Mor protein (5 min at 95_C) failed to crosslink at shorter incubation times (10 and 20 min), however, some crosslinking was observed after longer incubation.
Bending
The spacer region between the Mor footprint and the -10 region of P m contains a T 7 tract (seven consecutive T residues in positions -24 to -30) which is predicted to be rigid and cause an intrinsic ∼18_ bend in the DNA (29) . Single base substitutions at positions -25 and -26 had no effect on promoter activity, while those at -28 reduced activity to 60% of wild-type (data not shown). This result indicates that the T tract does not need to be 7 nt long for effective promoter activation, however, since all the mutants examined retained at least four consecutive T residues, it leaves open the possibility that the unusual DNA structure characteristic of T tracts plays a role in P m activation (29) .
To examine whether Mor induces a bend in P m DNA upon binding we employed a circular permutation assay developed by Wu and Crothers (35) , which is based on the anomalous migration of bent DNA fragments in acrylamide gels depending on the position of the protein-induced bend; retardation of the fragment is maximal when the bend is located in the center of the fragment. The minimal P m promoter (-61 to +10) was cloned into the XbaI site of pBend2 (20) and the resulting plasmid (pIA40) was Figure 5 . Gel retardation analysis of Mor binding to mutant promoter fragments. Assays were performed essentially as described by Carey (30) . P m probes 160 bp long were made by PCR with 32 P-labeled oligonucleotides IRI21 and IRI22. Different P m mutant fragments cloned into pIA12 were used as template in a standard 30 cycle amplification. Probes were purified away from labeled primers, [γ-32 P]ATP and Taq polymerase using a QIAquick spin PCR purification kit (Qiagen); concentration was determined spectrophotometrically and on ethidium bromide stained agarose gels. Negative control probe was prepared by PCR amplification of a fragment from the pBend2 vector and purified as above. Each reaction contained 1.2 × 10 -10 M probe and was carried out in 20 µl binding buffer (20 mM Tris-HCl, pH 7.9, 50 mM NaCl, 1 mM DTT, 10% glycerol) for 15 min at 25_C. Protein was diluted into binding buffer on ice immediately before use at 0, 10, 100 and 1000 ng Mor (corresponding to 4 × 10 -9 , 4 × 10 -8 and 4 × 10 -7 M active protein dimer respectively). Reactions were loaded on 8% acrylamide gels (29:1) in 0.5× TBE and run for 3 h at 8_C at 15 V/cm. Gels were exposed overnight with screen to X-OMAT AR film (Kodak) without drying. digested with restriction enzymes to yield eight circularly permuted DNA fragments of identical size (192 bp) and composition, differing only in the position of the Mor binding site. Complexes formed between purified Mor and labeled restriction fragments were analyzed electrophoretically in 10% non-denaturing gels (Fig. 7) . The mobilities of the Mor-DNA complexes were essentially identical, indicating that Mor does not introduce a significant bend into P m upon binding. Assays using different gel concentrations and temperatures also gave no evidence for a protein-induced bend.
DISCUSSION
This study identifies three regions within P m that are important for promoter activity. The first is the -10 region, known to be involved in binding of the σ 70 subunit of RNA polymerase holoenzyme (36) . The second is the Mor footprint region previously shown to be protected from DNase I cleavage by bound Mor (11) . Gel retardation analyses of promoter Down mutations in this region confirmed that they reduce Mor binding. Examination of the most important bases (-51 to -36) in this region revealed an imperfect 5 bp dyad symmetry element with a 6 bp spacer (AGTAAagccggTTAAT; Fig. 5B ), leading to the prediction that the centers of these repeats are separated by ∼1 helical turn, allowing binding of a Mor dimer on one side of the DNA helix. Consistent with this prediction, glutaraldehyde crosslinking of Mor in solution did produce a dimer-sized species. Nevertheless, the two halves of the symmetrical element may not be of equal importance, since mutations in the right half produced more dramatic reductions in both Mor binding and promoter (20) . Digestion with the following restriction enzymes generated eight circularly permuted fragments each 192 bp long: a, MluI; b, NheI; c, SpeI; d, DraI; e, PvuII; f, StuI; g, KpnI; h, BamHI. (Bottom) Electrophoretic analysis of complexes formed between purified Mor protein and promoter DNA fragments. Plasmid pIA40 was digested with restriction enzymes a-h and treated with phosphatase. The fragments were isolated from a gel by electroelution onto DE81 paper and ethanol precipitated. Pellets were resuspended in water, end-labeled with [γ-32 P]ATP with PNK and purified using a QIAquick spin PCR purification kit (Qiagen). Binding reactions were performed as in the gel retardation experiments, except that samples were loaded on 10% (29:1) gels under current and run at 8_C.
activity. This bias is unlikely to be due to better binding of Mor to TTAAT or to a completely symmetrical binding site, since the -50T mutation, generating a perfectly symmetrical site with two right half-sites, did not increase Mor binding or promoter activity and the -37C mutation, generating two left half-sites, did not decrease promoter activity or Mor binding. A similar bias was observed previously for the dyad symmetry element of the Mu late promoter P lys , which is activated by the related Mu protein C (19) .
The most interesting mutations were those in the third region, positions -29 to -31, between the Mor footprint and the -10 region. These positions usually overlap the -35 hexamer, however, the P m sequence bears no resemblance to the -35 consensus (TTGACA; 27). Both Up and Down mutations were found in this region, yet none had a detectable effect on Mor binding. One possible explanation for this finding is that nucleotides at these positions are involved in atypical interaction with RNA polymerase or in binding of an additional host factor. Alternatively, this region may undergo a conformational change during protein binding and promoter activation. DNase I footprinting with crude extract containing Mor resulted in hypersensitivity to cleavage between positions -29 and -32 (11), indicating a significant alteration in DNA structure. Simultaneous binding of purified Mor and RNA polymerase holoenzyme also resulted in hypersensitivity at positions -32 and -33 to potassium permanganate (manuscript in preparation), which reacts predominantly with T residues (and to a lesser extent with C residues) in distorted or single-stranded regions (37) . This distortion occurs at the junction of the rigid T tract with GC-rich DNA, a junction prone to deformation (29) . Base substitutions at positions -29, -30 and -31 causing Up and Down phenotypes would be expected to alter the DNA flexibility in this region and/or the position of the distortion (29) . It may be that distortion or unwinding (38, 39) of this region is necessary for the precise alignment of Mor and RNA polymerase, occuring as it does near the predicted interface of these two proteins. The requirement for precise spacing between the Mor footprint and the -10 region also indicates the importance of the helical angle between binding sites for both proteins.
